Trial · NCT05819658
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change From the Baseline in the Total Score of PSP-rating Scale | 24 weeks(6 months) | Change from the baseline in the total score of PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 100 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Total Score of PSP-rating Scale | 12 Weeks(3 months) | Change from the baseline in the total score of PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 100 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Montreal Cognitive Assessment - Korea (MoCAK) | 12 weeks (3 Months) | Change from the baseline in the Montreal Cognitive Assessment - Korea (MoCAK) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 30 with a higher score indicating greater cognitive function. |
| Secondary | Change From the Baseline in the Montreal Cognitive Assessment - Korea (MoCAK) | 24 weeks(6 months) | Change from the baseline in the Montreal Cognitive Assessment - Korea (MoCAK) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 30 with a higher score indicating greater cognitive function. |
| Secondary | Change From the Baseline in the Korean Frontal Assessment Battery (K-FAB) | 12 weeks(3 months) | Change from the baseline in the Korean Frontal Assessment Battery (K-FAB) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 18 with a higher score indicating greater cognitive function. |
| Secondary | Change From the Baseline in the Korean Frontal Assessment Battery (K-FAB) | 24 weeks(6 months) | Change from the baseline in the Korean Frontal Assessment Battery (K-FAB) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 18 with a higher score indicating greater cognitive function. |
| Secondary | Change From the Baseline in the England & Schwab Activity of Daily Living (ES ADL) Scale | 12 weeks(3 months) | Change from the baseline in the England \& Schwab Activity of Daily Living (ES ADL) scale after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 (complete dependence) to 100% (complete independence) based on the level of independence. |
| Secondary | Change From the Baseline in the England & Schwab Activity of Daily Living (ES ADL) Scale | 24 weeks(6 months) | Change from the baseline in the England \& Schwab Activity of Daily Living (ES ADL) scale after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 (complete dependence) to 100% (complete independence) based on the level of independence. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (History) | 12 weeks(3 months) | Change from the baseline in the score of \[History\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 24 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (History) | 24 weeks(6 months) | Change from the baseline in the score of \[History\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 24 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Mentation) | 12 weeks(3 months) | Change from the baseline in the score of \[Mentation\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 16 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Mentation) | 24 weeks(6 months) | Change from the baseline in the score of \[Mentation\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 16 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Bulbar) | 12 weeks(3 months) | Change from the baseline in the score of \[Bulbar\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 8 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Bulbar) | 24 weeks(6 months) | Change from the baseline in the score of \[Bulbar\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 8 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Ocular Motor) | 12 weeks(3 months) | Change from the baseline in the score of \[Ocular Motor\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 16 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Ocular Motor) | 24 weeks(6 months) | Change from the baseline in the score of \[Ocular Motor\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 16 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Limb Motor) | 12 weeks(3 months) | Change from the baseline in the score of \[Limb Motor\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 16 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Limb Motor) | 24 weeks(6 months) | Change from the baseline in the score of \[Limb Motor\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 16 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Midline/Gait) | 12 weeks(3 months) | Change from the baseline in the score of \[Midline/Gait\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 12 weeks (3 months) of investigational product administration. The possible total scores range from 0 to 20 with a higher score indicating severely impaired cognitive function. |
| Secondary | Change From the Baseline in the Score of Each Domain of the PSP-rating Scale (Midline/Gait) | 24 weeks(6 months) | Change from the baseline in the score of \[Midline/Gait\] domain of the PSP-rating scale(Progressive Supranuclear Palsy Rating Scale) after 24 weeks (6 months) of investigational product administration. The possible total scores range from 0 to 20 with a higher score indicating severely impaired cognitive function. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05819658/registered